Skip to main navigation Skip to search Skip to main content

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

  • Brian Godman
  • , Rickard Malmström
  • , Eduardo Diogène
  • , Andy Gray
  • , Sisira Jayathissa
  • , Angela Timoney
  • , Francisco Acúrcio
  • , Ali Alkan
  • , Anna Brzezinska
  • , Anna Bucsics
  • , Stephen Campbell
  • , Jadwiga Czeczot
  • , Winnie De Bruyn
  • , Irene Eriksson
  • , Faridah Yusof
  • , Alexander Finlayson
  • , Jurij Fürst
  • , Kristina Garuolienè
  • , Augusto Guerra Júnior
  • , Jolanta Gulbinovic
    • Saira Jan, Roberta Joppi, Marija Kalaba, Einar Magnisson, Laura McCullagh, Kaisa Miikkulainen, Gabriela Ofierska-Sujkowska, Hanne Bak Pedersen, Gisbert Selke, Catherine Sermet, Susan Spillane, Azuwana Supian, Ilse Truter, Vera Vlahovic-Palcevski, Low Ee Vien, Elif H Vural, Janet Wale, Magdalena Wladysiuk, Wenjie Zeng, Lars L Gustafsson

Research output: Contribution to journal › Article › peer-review

112   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science